Final-Program-ATS-2023-AP.vp

342

WEDNESDAY • MAY 24

208 Drug Withdrawn Pneumonitis? A Case of an Acute Pneumonitis Associated With Ruxolitinib Withdrawal/ J. Blount, Sacramento, CA 209 A Man With Palbociclib-Induced Pneumonitis: A Very Rare Entity/ M. Alsharif, Springfield, IL 210 Belantamab Mafodotin Induced Pneumonitis and Pulmonary Fibrosis/ D. Mehta, Chapel Hill, NC 211 Delayed Mitomycin-Induced Pulmonary Veno-Occlusive Disease/ T. Papidze, Chapel Hill, NC 212 Pulmonary Hypertension in a Patient With Multiple Myeloma/ B. Zafar, Houston, TX 213 Hydralazine Induced Pulmonary Renal Syndrome Via Anca Associated Vasculitis/ S. Shireen Kanamgode, Worcester, MA 214 A Case of Rituximab-induced Interstitial Lung Disease/ S. Nagpal, Johnson, TN 215 Vaping and Cystic Lung Disease: An Underrecognized Relationship/ Q. Alitter, Hialeah, FL 216 How Harmful Is Cocaine? A Case Of Cocaine Induced Constrictive Bronchiolitis/ R. Kumra, Phoenix, AZ 217 The Use of Prolonged Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) as a Lifesaving Therapy for a Patient With Chlorine Gas Inhalation Injury: A Case Report/ S.A. Henry, Hershey, PA 218 Baby Powder and Protein in an Unexpected Cause of Dyspnea in Pregnancy/ B. Berger, Durham, NC 219 Methemoglobinemia and Home Oximetry/ M. Haley, Portland, OR 220 A Case Of Severe Colchicine Associated Vacuolar Myopathy And Respiratory Failure/ D. Narayanan, Los Angeles, CA D104 CARDIAC AND VASCULAR CRITICAL CARE: THE BEST CASE REPORTS FROM 2022 12:00 p.m. - 2:00 p.m. Walter E. Washington Convention Center Room 209 A-C (Level 2) Poster Viewing 12:00-12:45 Discussion 12:45-2:00 Chairing: M. Parotto, MD, PhD, Toronto, Canada M.J. Lanspa, MD, MSCR, ATSF, Salt Lake City, UT M.M. Hayes, MD, ATSF, Boston, MA CLINICAL POSTER DISCUSSION SESSION

522 Efficacy and Tolerability of AXA1125, an Endogenous Metabolic Modulator Composition, in Fatigue-predominant Long COVID: A Randomized, Double-blind, Placebo-controlled Study/ L. Finnigan, Oxford, United Kingdom 523 Regional Differences in the Substance Use Epidemic Among Adult Intensive Care Unit Patients/ K. Hills-Evans, Aurora, CO 524 Clinical Effort Against Smoke Exposure in CF (CEASE-CF): Feasibility, Acceptability, and Preliminary Efficacy/ G.R. Oates, Birmingham, AL 525 Risk Factors for Increased Healthcare Utilization After Pediatric Sepsis Hospitalization/ E.F. Carlton, Ann Arbor, MI D103 THE DOUBLE EDGED SWORD: DRUG TOXICITY CASE REPORTS 12:00 p.m. - 2:00 p.m. Walter E. Washington Convention Center Room 103 A-B (Street Level) Poster Viewing 12:00-12:45 Discussion 12:45-2:00 Chairing: V. Cottin, MD, PhD, Lyon, France S.E. Hines, MD, MSPH, Baltimore, MD T. Paul, MD, Charlottesville, VA 201 A Case of Naltrexone Induced Acute Eosinophilic Pneumonia/ Y. Abdelghany, Baltimore, MD 202 Some Supplements Are Detriments of Health: A Case of Lysine Induced Eosinophilic Pneumonia/ S. Jothi, Tucson, AZ 203 Acute Fibrinous and Organizing Pneumonia Due to Sirolimus Induced Lung Toxicity in a Bilateral Lung Transplant Patient/ B. Goodman, Detroit, MI 204 A Case of Sarcoidosis-Like Reaction With Mediastinal Adenopathy in a Patient With Acinar Adenocarcinoma of the Lung Caused by Checkpoint Inhibitor Immunotherapy/ J. Kent, Dallas, TX 205 A Cascade of Trouble/ J. Kodela, Worcester, MA 206 Is It the Lung? Or the Heart? Or Both? - A Case of Pembrolizumab-Induced Cardiopulmonary Toxicity/ M. Ghose, Long Branch, NJ 207 Clinical Course And Typical Chest CT Findings Of Olaparib-induced Lung Injury: A Case Series/ M. Hattori, Tokyo, Japan CLINICAL POSTER DISCUSSION SESSION

ATS 2023 • Washington, DC